Picture of Tenax Therapeutics logo

TENX Tenax Therapeutics Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for Tenax Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-8.39-9.85-32.5-11-7.71
Depreciation
Non-Cash Items0.3730.4722.20.4710.192
Unusual Items
Other Non-Cash Items
Changes in Working Capital0.460.104-0.609-1.441.61
Change in Accounts Receivable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Other Operating Cash Flow
Cash from Operating Activities-7.56-9.27-10.9-12-5.9
Capital Expenditures-0.004-0.003-0.005-0.002
Purchase of Fixed Assets
Other Investing Cash Flow Items0.0020.0240.45800.003
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities-0.0020.020.453-0.0020.003
Financing Cash Flow Items7.9314.2
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities0.09710.69.748.5513.6
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-7.461.34-0.666-3.467.67